Molecular pharmacology of human NMDA receptors

Neurochemistry International

Volumn 61, Issue 4, 2012, Pages 601-609

  Hedegaard, Maiken ^a,b   Hansen, Kasper B ^a   Andersen, Karen T ^a,b   Bräuner Osborne, Hans ^b   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Electrophysiology; Ionotropic glutamate receptor; NMDA; Pharmacology; Structure function

Indexed keywords

CALCIUM; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHANNEL GATING; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; HUMAN; HUMAN CELL; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SPECIES COMPARISON;

ANIMALS; HUMANS; LIGANDS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SPECIES SPECIFICITY;

ANIMALIA; RATTUS; RODENTIA;

EID: 84865785574     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.11.016     Document Type: Article

References (70)

1. T.M. Acker, H. Yuan, K.B. Hansen, K.M. Vance, K.K. Ogden, H.S. Jensen, P.B. Burger, P. Mullasseril, J.P. Snyder, D.C. Liotta, and S.F. Traynelis Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-d-aspartate receptor subunit-selective modulators Mol. Pharmacol. 80 2011 782 795
2. M.G. Annetta, D. Iemma, C. Garisto, C. Tafani, and R. Proietti Ketamine: new indications for an old drug Curr. Drug Targets 6 2005 789 794
3. T.G. Banke, and S.F. Traynelis Activation of NR1/NR2B NMDA receptors Nat. Neurosci. 6 2003 144 152
4. B. Bednar, M.E. Cunningham, L. Kiss, G. Cheng, J.A. McCauley, N.J. Liverton, and K.S. Koblan Kinetic characterization of novel NR2B antagonists using fluorescence detection of calcium flux J. Neurosci. Methods 137 2004 247 255
5. J.D. Bendtsen, H. Nielsen, G. von Heijne, and S. Brunak Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol 340 2004 783 795
6. P.E. Chen, M.T. Geballe, E. Katz, K. Erreger, M.R. Livesey, K.K. O'Toole, P. Le, C.J. Lee, J.P. Snyder, S.F. Traynelis, and D.J. Wyllie Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol. 586 2008 227 245
7. C.F. Claiborne, J.A. McCauley, B.E. Libby, N.R. Curtis, H.J. Diggle, J.J. Kulagowski, S.R. Michelson, K.D. Anderson, D.A. Claremon, R.M. Freidinger, R.A. Bednar, S.D. Mosser, S.L. Gaul, T.M. Connolly, C.L. Condra, B. Bednar, G.L. Stump, J.J. Lynch, A. Macaulay, K.A. Wafford, K.S. Koblan, and N.J. Liverton Orally efficacious NR2B-selective NMDA receptor antagonists Bioorg. Med. Chem. Lett. 13 2003 697 700
8. C. Collins, C. Duff, A.M. Duncan, R. Planells-Cases, W. Sun, A. Norremolle, E. Michaelis, M. Montal, R. Worton, and M.R. Hayden Mapping of the human NMDA receptor subunit (NMDAR1) and the proposed NMDA receptor glutamate-binding subunit (NMDARA1) to chromosomes 9q34.3 and chromosome 8, respectively Genomics 17 1993 237 239
9. B.M. Costa, M.W. Irvine, G. Fang, R.J. Eaves, M.B. Mayo-Martin, D.A. Skifter, D.E. Jane, and D.T. Monaghan A novel family of negative and positive allosteric modulators of NMDA receptors J. Pharmacol. Exp. Ther. 335 2010 614 621
10. N.R. Curtis, H.J. Diggle, J.J. Kulagowski, C. London, S. Grimwood, P.H. Hutson, F. Murray, P. Richards, A. Macaulay, and K.A. Wafford Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonists Bioorg. Med. Chem. Lett. 13 2003 693 696
11. L.P. Daggett, E.C. Johnson, M.A. Varney, F.F. Lin, S.D. Hess, C.R. Deal, C. Jachec, C.C. Lu, J.A. Kerner, G.B. Landwehrmeyer, D.G. Standaert, A.B. Young, M.M. Harpold, and G. Velicelebi The human N-methyl-d-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression J. Neurochem. 71 1998 1953 1968
12. S.M. Dravid, K. Erreger, H. Yuan, K. Nicholson, P. Le, P. Lyuboslavsky, A. Almonte, E. Murray, C. Mosely, J. Barber, A. French, R. Balster, T.F. Murray, and S.F. Traynelis Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block J. Physiol. 581 2007 107 128
13. S.M. Dravid, A. Prakash, and S.F. Traynelis Activation of recombinant NR1/NR2C NMDA receptors J. Physiol. 586 2008 4425 4439
14. M.D. Ehlers, S. Zhang, J.P. Bernhadt, and R.L. Huganir Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit Cell 84 1996 745 755
15. K. Erreger, S.M. Dravid, T.G. Banke, D.J. Wyllie, and S.F. Traynelis Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles J. Physiol. 563 2005 345 358
16. K. Erreger, M.T. Geballe, A. Kristensen, P.E. Chen, K.B. Hansen, C.J. Lee, H. Yuan, P. Le, P.N. Lyuboslavsky, N. Micale, L. Jorgensen, R.P. Clausen, D.J. Wyllie, J.P. Snyder, and S.F. Traynelis Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-d-aspartate glutamate receptors Mol. Pharmacol. 72 2007 907 920
17. D. Feuerbach, E. Loetscher, S. Neurdin, and M. Koller Comparative pharmacology of the human NMDA-receptor subtypes R1-2A, R1-2B, R1-2C and R1-2D using an inducible expression system Eur. J. Pharmacol. 637 2010 46 54
18. R.L. Foldes, V. Rampersad, and R.K. Kamboj Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-d-aspartate receptor subunits: evidence for alternative RNA splicing Gene 131 1993 293 298
19. R.L. Foldes, S.L. Adams, R.P. Fantaske, and R.K. Kamboj Human N-methyl-d-aspartate receptor modulatory subunit hNR2A: cloning and sequencing of the cDNA and primary structure of the protein Biochim. Biophys. Acta 1223 1994 155 159
20. R.L. Foldes, V. Rampersad, and R.K. Kamboj Cloning and sequence analysis of additional splice variants encoding human N-methyl-d-aspartate receptor (hNR1) subunits Gene 147 1994 303 304
21. M. Gielen, R.B. Siegler, L. Mony, J.W. Johnson, and P. Paoletti Mechanism of differential control of NMDA receptor activity by NR2 subunits Nature 459 2009 703 707
22. 2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites J. Neurochem. 66 1996 2589 2595
23. S. Grimwood, B.B. Le, J.R. Atack, C. Barton, W. Cockett, S.M. Cook, E. Gilbert, P.H. Hutson, R.M. McKernan, J. Myers, C.I. Ragan, P.B. Wingrove, and P.J. Whiting Generation and characterisation of stable cell lines expressing recombinant human N-methyl-d-aspartate receptor subtypes J. Neurochem. 66 1996 2239 2247
24. P.J. Hallett, and D.G. Standaert Rationale for and use of NMDA receptor antagonists in Parkinson's disease Pharmacol. Ther. 102 2004 155 174
25. K.B. Hansen, and S.F. Traynelis Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors J. Neurosci. 31 2011 3650 3661
26. K.B. Hansen, H. Bräuner-Osborne, and J. Egebjerg Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements Comb. Chem. High Throughput Screen. 11 2008 304 315
27. K.B. Hansen, H. Furukawa, and S.F. Traynelis Control of assembly and function of glutamate receptors by the amino-terminal domain Mol. Pharmacol. 78 2010 535 549
28. K.B. Hansen, P. Mullasseril, S. Dawit, N.L. Kurtkaya, H. Yuan, K.M. Vance, A.G. Orr, T. Kvist, K.K. Ogden, P. Le, K.M. Vellano, I. Lewis, S. Kurtkaya, Y. Du, M. Qui, T.J. Murphy, J.P. Snyder, H. Bräuner-Osborne, and S.F. Traynelis Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-d-aspartate receptor antagonists J. Pharmacol. Exp. Ther. 333 2010 650 662
29. G.E. Hardingham, and H. Bading Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders Nat. Rev. Neurosci. 11 2010 682 696
30. S.D. Hess, L.P. Daggett, J. Crona, C. Deal, C.C. Lu, A. Urrutia, L. Chavez-Noriega, S.B. Ellis, E.C. Johnson, and G. Velicelebi Cloning and functional characterization of human heteromeric N-methyl-d-aspartate receptors J. Pharmacol. Exp. Ther. 278 1996 808 816
31. S.D. Hess, L.P. Daggett, C. Deal, C.C. Lu, E.C. Johnson, and G. Velicelebi Functional characterization of human N-methyl-d-aspartate subtype 1A/2D receptors J. Neurochem. 70 1998 1269 1279
32. S. Jones, and A.J. Gibb Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones J. Physiol. 569 2005 209 221
33. L.V. Kalia, S.K. Kalia, and M.W. Salter NMDA receptors in clinical neurology: excitatory times ahead Lancet Neurol. 7 2008 742 755
34. E. Karakas, N. Simorowski, and H. Furukawa Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors Nature 475 2011 249 253
35. S.J. Karp, M. Masu, T. Eki, K. Ozawa, and S. Nakanishi Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-d-aspartate receptor J. Biol. Chem. 268 1993 3728 3733
36. G. Kohr, and P.H. Seeburg Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family J. Physiol. 492 Pt 2 1996 445 452
37. M. Koller, and S. Urwyler Novel N-methyl-d-aspartate receptor antagonists: a review of compounds patented since 2006 Expert Opin. Ther. Pat. 20 2010 1683 1702
38. J.J. Krupp, B. Vissel, S.F. Heinemann, and G.L. Westbrook N-terminal domains in the NR2 subunit control desensitization of NMDA receptors Neuron 20 1998 317 327
39. C.G. Lau, and R.S. Zukin NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders Nat. Rev. Neurosci. 8 2007 413 426
40. B. Le Bourdelles, K.A. Wafford, J.A. Kemp, G. Marshall, C. Bain, A.S. Wilcox, J.M. Sikela, and P.J. Whiting Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits J. Neurochem. 62 1994 2091 2098
41. Y.J. Lin, S. Bovetto, J.M. Carver, and T. Giordano Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery Brain Res. Mol. Brain Res. 43 1996 57 64
42. S.A. Lipton Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond Nat. Rev. Drug Discov. 5 2006 160 170
43. C.M. Low, and K.S. Wee New insights into the not-so-new NR3 subunits of N-methyl-d-aspartate receptor: localization, structure, and function Mol. Pharmacol. 78 2010 1 11
44. H. Monyer, R. Sprengel, R. Schoepfer, A. Herb, M. Higuchi, H. Lomeli, N. Burnashev, B. Sakmann, and P.H. Seeburg Heteromeric NMDA receptors: molecular and functional distinction of subtypes Science 256 1992 1217 1221
45. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
46. C.A. Mosley, T.M. Acker, K.B. Hansen, P. Mullasseril, K.T. Andersen, P. Le, K.M. Vellano, H. Bräuner-Osborne, D.C. Liotta, and S.F. Traynelis Quinazolin-4-one derivatives: a novel class of noncompetitive NR2C/D subunit-selective N-methyl-d-aspartate receptor antagonists J. Med. Chem. 53 2010 5476 5490
47. P. Mullasseril, K.B. Hansen, K.M. Vance, K.K. Ogden, H. Yuan, N.L. Kurtkaya, R. Santangelo, A.G. Orr, P. Le, K.M. Vellano, D.C. Liotta, and S.F. Traynelis A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors Nat. Commun. 1 2010 90
48. R. Planells-Cases, W. Sun, A.V. Ferrer-Montiel, and M. Montal Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-d-aspartate receptor subunit from human brain Proc. Natl. Acad. Sci. U S A 90 1993 5057 5061
49. S.H. Preskorn, B. Baker, S. Kolluri, F.S. Menniti, M. Krams, and J.W. Landen An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder J. Clin. Psychopharmacol. 28 2008 631 637
50. T. Priestley, P. Laughton, J. Myers, B.B. Le, J. Kerby, and P.J. Whiting Pharmacological properties of recombinant human N-methyl-d-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells Mol. Pharmacol. 48 1995 841 848
51. T. Priestley, P. Laughton, A.J. Macaulay, R.G. Hill, and J.A. Kemp Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324 Neuropharmacology 35 1996 1573 1581
52. S. Schorge, S. Elenes, and D. Colquhoun Maximum likelihood fitting of single channel NMDA activity with a mechanism composed of independent dimers of subunits J. Physiol. 569 2005 395 418
53. P. Skolnick, P. Popik, and R. Trullas Glutamate-based antidepressants: 20 years on Trends Pharmacol. Sci. 30 2009 563 569
54. A.I. Sobolevsky, M.P. Rosconi, and E. Gouaux X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor Nature 462 2009 745 756
55. R.D. Steinmetz, E. Fava, P. Nicotera, and D. Steinhilber A simple cell line based in vitro test system for N-methyl-d-aspartate (NMDA) receptor ligands J. Neurosci. Methods 113 2002 99 110
56. R.D. Steinmetz, B. Firla, and D. Steinhilber Inhibition of the functional expression of N-methyl-d-aspartate receptors in a stably transformed cell line by cyclosporin A Biochem. Pharmacol. 68 2004 563 571
57. P. Stern, P. Behe, R. Schoepfer, and D. Colquhoun Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors Proc. Biol. Sci. 250 1992 271 277
58. S.F. Traynelis, M.F. Burgess, F. Zheng, P. Lyuboslavsky, and J.L. Powers Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit J. Neurosci. 18 1998 6163 6175
59. S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K. Ogden, K.B. Hansen, H. Yuan, S.J. Myers, and R. Dingledine Glutamate receptor ion channels: structure, regulation, and function Pharmacol. Rev. 62 2010 405 496
60. M. Usala, S.A. Thompson, P.J. Whiting, and K.A. Wafford Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors Br. J. Pharmacol. 140 2003 1045 1050
61. M.A. Varney, C. Jachec, C. Deal, S.D. Hess, L.P. Daggett, R. Skvoretz, M. Urcan, J.H. Morrison, T. Moran, E.C. Johnson, and G. Velicelebi Stable expression and characterization of recombinant human heteromeric N-methyl-d-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells J. Pharmacol. Exp. Ther. 279 1996 367 378
62. S. Vicini, J.F. Wang, J.H. Li, W.J. Zhu, Y.H. Wang, J.A.H. Luo, B.B. Wolfe, and D.R. Grayson Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors J. Neurophysiol. 79 1998 555 566
63. B. Vissel, J.J. Krupp, S.F. Heinemann, and G.L. Westbrook A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux Nat. Neurosci. 4 2001 587 596
64. K.A. Wafford, M. Kathoria, C.J. Bain, G. Marshall, B.B. Le, J.A. Kemp, and P.J. Whiting Identification of amino acids in the N-methyl-d-aspartate receptor NR1 subunit that contribute to the glycine binding site Mol. Pharmacol. 47 1995 374 380
65. E.A. Waxman, and D.R. Lynch N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease Neuroscientist 11 2005 37 49
66. K. Williams Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor - selectivity and mechanisms at recombinant heteromeric receptors Mol. Pharmacol. 44 1993 851 859
67. D.J. Wyllie, P. Behe, M. Nassar, R. Schoepfer, and D. Colquhoun Single-channel currents from recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes Proc. Biol. Sci. 263 1996 1079 1086
68. D.J. Wyllie, P. Behe, and D. Colquhoun Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors J. Physiol. 510 Pt 1 1998 1 18
69. H. Yuan, K.B. Hansen, K.M. Vance, K.K. Ogden, and S.F. Traynelis Control of NMDA receptor function by the NR2 subunit amino-terminal domain J. Neurosci. 29 2009 12045 12058
70. L. Yurkewicz, J. Weaver, M.R. Bullock, and L.F. Marshall The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury J. Neurotrauma 22 2005 1428 1443